Ad is loading...
ACHV
Price
$4.60
Change
+$0.04 (+0.88%)
Updated
Dec 4, 11:06 AM (EDT)
99 days until earnings call
CDTX
Price
$17.71
Change
-$1.05 (-5.60%)
Updated
Dec 3 closing price
Ad is loading...

ACHV vs CDTX

Header iconACHV vs CDTX Comparison
Open Charts ACHV vs CDTXBanner chart's image
Achieve Life Sciences
Price$4.60
Change+$0.04 (+0.88%)
Volume$318
CapitalizationN/A
Cidara Therapeutics
Price$17.71
Change-$1.05 (-5.60%)
Volume$62.75K
CapitalizationN/A
ACHV vs CDTX Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACHV vs. CDTX commentary
Dec 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a StrongBuy and CDTX is a StrongSell.

COMPARISON
Comparison
Dec 04, 2024
Stock price -- (ACHV: $4.56 vs. CDTX: $17.71)
Brand notoriety: ACHV and CDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 147% vs. CDTX: 159%
Market capitalization -- ACHV: $156.82M vs. CDTX: $205.21M
ACHV [@Biotechnology] is valued at $156.82M. CDTX’s [@Biotechnology] market capitalization is $205.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $485.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileCDTX’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • CDTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CDTX is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 6 TA indicator(s) are bullish while CDTX’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 6 bullish, 5 bearish.
  • CDTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than CDTX.

Price Growth

ACHV (@Biotechnology) experienced а +1.79% price change this week, while CDTX (@Biotechnology) price change was -9.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.51%. For the same industry, the average monthly price growth was +3.66%, and the average quarterly price growth was +12.99%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 13, 2025.

CDTX is expected to report earnings on Aug 13, 2024.

Industries' Descriptions

@Biotechnology (+5.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($205M) has a higher market cap than ACHV($157M). CDTX YTD gains are higher at: 11.524 vs. ACHV (10.680). ACHV has higher annual earnings (EBITDA): -29.95M vs. CDTX (-127.83M). CDTX has more cash in the bank: 127M vs. ACHV (42.9M). CDTX has less debt than ACHV: CDTX (3.94M) vs ACHV (9.85M). CDTX has higher revenues than ACHV: CDTX (44.7M) vs ACHV (0).
ACHVCDTXACHV / CDTX
Capitalization157M205M77%
EBITDA-29.95M-127.83M23%
Gain YTD10.68011.52493%
P/E RatioN/AN/A-
Revenue044.7M-
Total Cash42.9M127M34%
Total Debt9.85M3.94M250%
FUNDAMENTALS RATINGS
ACHV vs CDTX: Fundamental Ratings
ACHV
CDTX
OUTLOOK RATING
1..100
6427
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6336
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for ACHV (63). This means that CDTX’s stock grew somewhat faster than ACHV’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ACHV (100). This means that CDTX’s stock grew similarly to ACHV’s over the last 12 months.

CDTX's SMR Rating (99) in the Biotechnology industry is in the same range as ACHV (99). This means that CDTX’s stock grew similarly to ACHV’s over the last 12 months.

CDTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as ACHV (63). This means that CDTX’s stock grew similarly to ACHV’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ACHV (100). This means that CDTX’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVCDTX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 29 days ago
84%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPQMX11.180.03
+0.27%
Principal MidCap Growth III R3
MABBX10.08N/A
N/A
Morgan Stanley US Focus Real Estate C
HSMYX15.12-0.08
-0.53%
Hartford Small Cap Value Y
OLVTX23.07-0.13
-0.56%
JPMorgan Large Cap Value R3
PSOAX28.44-0.20
-0.70%
JPMorgan Small Cap Value A

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-5.60%
BPTSY - CDTX
92%
Closely correlated
N/A
IVVD - CDTX
36%
Loosely correlated
-8.32%
CPRX - CDTX
35%
Loosely correlated
-3.64%
CABA - CDTX
33%
Poorly correlated
-13.80%
TRAW - CDTX
30%
Poorly correlated
-0.38%
More